» Articles » PMID: 36984771

Mapping the Metabolic Niche of Citrate Metabolism and

Overview
Journal Metabolites
Publisher MDPI
Date 2023 Mar 29
PMID 36984771
Authors
Affiliations
Soon will be listed here.
Abstract

The small molecule citrate is a key molecule that is synthesized de novo and involved in diverse biochemical pathways influencing cell metabolism and function. Citrate is highly abundant in the circulation, and cells take up extracellular citrate via the sodium-dependent plasma membrane transporter NaCT encoded by the gene. Citrate is critical to maintaining metabolic homeostasis and impaired NaCT activity is implicated in metabolic disorders. Though citrate is one of the best known and most studied metabolites in humans, little is known about the consequences of altered citrate uptake and metabolism. Here, we review recent findings on , NaCT, and citrate metabolism and discuss the effects on metabolic homeostasis and -dependent phenotypes. We discuss the "multiple-hit theory" and how stress factors induce metabolic reprogramming that may synergize with impaired NaCT activity to alter cell fate and function. Furthermore, we underline how citrate metabolism and compartmentalization can be quantified by combining mass spectrometry and tracing approaches. We also discuss species-specific differences and potential therapeutic implications of and NaCT. Understanding the synergistic impact of multiple stress factors on citrate metabolism may help to decipher the disease mechanisms associated with SLC13A5 citrate transport disorders.

Citing Articles

Novel Approaches to Studying SLC13A5 Disease.

Beltran A Metabolites. 2024; 14(2).

PMID: 38392976 PMC: 10890222. DOI: 10.3390/metabo14020084.

References
1.
Pajor A, de Oliveira C, Song K, Huard K, Shanmugasundaram V, Erion D . Molecular Basis for Inhibition of the Na+/Citrate Transporter NaCT (SLC13A5) by Dicarboxylate Inhibitors. Mol Pharmacol. 2016; 90(6):755-765. DOI: 10.1124/mol.116.105049. View

2.
Sul J, Kim T, Yoo H, Kim J, Suh Y, Hwang J . A novel mechanism for the pyruvate protection against zinc-induced cytotoxicity: mediation by the chelating effect of citrate and isocitrate. Arch Pharm Res. 2016; 39(8):1151-9. DOI: 10.1007/s12272-016-0814-9. View

3.
Cordes T, Kuna R, McGregor G, Khare S, Gengatharan J, Muthusamy T . 1-Deoxysphingolipid synthesis compromises anchorage-independent growth and plasma membrane endocytosis in cancer cells. J Lipid Res. 2022; 63(10):100281. PMC: 9587408. DOI: 10.1016/j.jlr.2022.100281. View

4.
Klotz J, Porter B, Colas C, Schlessinger A, Pajor A . Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay. Mol Med. 2016; 22. PMC: 5023510. DOI: 10.2119/molmed.2016.00077. View

5.
Schaller L, Lauschke V . The genetic landscape of the human solute carrier (SLC) transporter superfamily. Hum Genet. 2019; 138(11-12):1359-1377. PMC: 6874521. DOI: 10.1007/s00439-019-02081-x. View